Shopping Cart
Remove All
Your shopping cart is currently empty
Leucettine L41 (LeucettineL41) is a selective DYRK1A inhibitor that inhibits DYRK2, CLK1, and CLK3, inducing autophagy linked to CLK inhibition. It is used to study Alzheimer's disease and memory deficits.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $81 | In Stock | In Stock | |
| 5 mg | $198 | In Stock | In Stock | |
| 10 mg | $373 | - | In Stock | |
| 25 mg | $616 | - | In Stock | |
| 50 mg | $872 | - | In Stock |
| Description | Leucettine L41 (LeucettineL41) is a selective DYRK1A inhibitor that inhibits DYRK2, CLK1, and CLK3, inducing autophagy linked to CLK inhibition. It is used to study Alzheimer's disease and memory deficits. |
| Targets&IC50 | CLK3:4.5 µM, Dyrk2:0.035 µM, CLK1:0.015 µM, Dyrk1A:0.04 µM |
| In vitro | Leucettine L41 is a potent inhibitor of bispecic tyrosine phosphorylated regulated kinase 1A (DYRK1A), DYRK2, CDC-like kinase 1 (CLK1), and CLK3 with IC50 of 0.04, 0.035, 0.015, and 4.5 µM, respectively. Leucettine L41 inhibits phosphorylation of serine/arginine-rich protein (SRp). [1] |
| In vivo | Leucettine L41(0.4, 1.2, 4 μg) prevented Aβ25-35-induced hippocampal memory impairment and neurotoxicity in mice. [2] Leucettine L41(20 mg/kg, peritoneal injection) AAV-AD rat model showed decreased soluble P-tau form but unchanged soluble Aβ42 level. [4] |
| Synonyms | LeucettineL41 |
| Molecular Weight | 307.3 |
| Formula | C17H13N3O3 |
| Cas No. | 1112978-84-3 |
| Smiles | C(\C=1C=C2C(=CC1)OCO2)=C/3\NC(NC4=CC=CC=C4)=NC3=O |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80.00 mg/mL (260.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.74 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.